Bertram Köhler

Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service.

Nanotron Technologies GmbH develops and provides wireless communications systems. The firm’s platform consists of chips, modules, and software that enable real-time positioning and concurrent wireless communication. Its products include swarm, nano location systems (RTLS), and transceiver. The company was founded by Manfred Koslar and Zbigniew Ianelli in 1991 and is headquartered in Berlin, Germany.

SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany.

Part of Deutsche Effecten & Wechsel Beteiligungs AG, Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) specializes in private equity fund. The private company is based in Jena, Germany.

4Flow AG offers consulting services and software in the field of logistics and supply chain management. It caters automotive manufacturers, suppliers, consumer goods and retail, renewable energy, telecommunications, medical technology, machinery manufacturers, basic materials industry, spare parts, packaging industry, logistics service providers (LSP) and small and medium businesses. The firm has offices in Belgium, Brazil, China, Czech Republic, Hungary and USA. The company was founded by Stefan Wolff and Kai Althoff in 2000 and is headquartered in Berlin, Germany.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.